Screener
ANI Pharmaceuticals ANIP Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Cash Flows From Investing Activities | ||
| Acquisition of product rights, intangible assets, and other related assets | (5,250) | (20,267) |
| Acquisition of property and equipment, net | (9,128) | (6,488) |
| Net Cash and Cash Equivalents Used in Investing Activities | (14,378) | (26,755) |
| Cash Flows From Financing Activities | ||
| Principal payments on borrowings | (8,125) | (4,062) |
| Series A convertible preferred stock dividends paid | — | (813) |
| Proceeds from stock option exercises and ESPP purchases | 2,510 | 3,776 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is ANI Pharmaceuticals's investing cash flow?
- ANI Pharmaceuticals (ANIP) reported investing cash flow of -$3.05M in Q2 2026.
- How has ANI Pharmaceuticals's investing cash flow changed year-over-year?
- ANI Pharmaceuticals's investing cash flow increased by 55.8% year-over-year, from -$6.91M to -$3.05M.
- What is the long-term trend for ANI Pharmaceuticals's investing cash flow?
- Over 4 years (2021 to 2025), ANI Pharmaceuticals's investing cash flow has grown at a -24.5% compound annual growth rate (CAGR), from -$105.48M to -$34.32M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about ANI Pharmaceuticals's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude